Clare McGrane
Vera Whole Health raises $5M to open six new employer-sponsored primary care clinics, expanding a membership-based model
Vera Whole Health operates employer-sponsored primary care clinics with a per-employee monthly membership model and has raised $5 million to open six more clinics, aiming to expand its workplace-focused approach to reshape U.S. healthcare.
Nelson Del Rio Joins Seattle Startup Blokable as Co-CEO to Advance Scalable Affordable Housing Solutions
Nelson Del Rio has joined Seattle startup Blokable as co-CEO, working alongside co-founder Aaron Holm to develop scalable modular housing solutions for affordable housing. Del Rio brings expertise in public-private partnerships and aims to transform the residential housing development process amid the ongoing housing crisis.
SafKan Health raises $1M seed to roll out OtoSet ear-cleaning headphones to U.S. hospitals
Seattle startup SafKan Health raised $1 million in seed funding to launch OtoSet, a headphone-like device that automatically flushes impacted earwax in about 35 seconds, into West Coast hospitals. Initial users will be medical professionals at University of Washington Medicine, Stanford Medicine, Cedars-Sinai, and Providence Saint John’s Health Center, with a consumer rollout planned later.
Moz Co-founder Gillian Muessig Launches Sybilla Masters Fund to Back Startups with Women Leaders, Aiming for $100M
Gillian Muessig launched the Sybilla Masters Fund to invest in startups with at least one woman founder or C-suite member, aiming to reach a $2 million initial close and ultimately raise $100 million while applying a gender-lensed investment approach.
Stratos Genomics raises $20M from Fisk Ventures to commercialize SBX nanopore DNA sequencing, total funding tops $50M
Stratos Genomics raised $20 million from Fisk Ventures to finalize commercialization of its Sequencing By Expansion (SBX) nanopore-based DNA sequencing technology, bringing total funding to over $50 million. The company says SBX is faster, cheaper and highly accurate, aiming to enter healthcare, research, agriculture and biotech markets within the coming year.
Immusoft raises $3M Series B tranche, names Sean Ainsworth CEO as Hurler’s Syndrome therapy nears human trials
Immusoft raised $3 million as the first tranche of its Series B to advance a Hurler’s Syndrome gene therapy into human trials, and appointed veteran biotech executive Sean Ainsworth as CEO while founder Matthew Scholz becomes CTO.
Wiserg raises $19.2M (total $56M) to scale food-scrap-to-fertilizer tech as former Microsoft/Amazon exec Brian Valentine becomes CEO
Wiserg, which makes a device that converts food scraps into nutrient-rich liquid fertilizer, raised $19.2 million (bringing total funding to $56 million) to expand across the Eastern U.S., South and Central America, and build a Southern California plant. Longtime investor Brian Valentine — a former Microsoft and Amazon executive — became CEO in July 2016 to scale the company beyond its research phase.
Joylux raises $5M Series A and readies vSculpt pelvic‑floor wellness device for U.S. launch
Seattle femtech startup Joylux is launching its vSculpt pelvic-floor ‘intimate wellness’ device in the U.S. while securing a committed $5 million Series A (after a $500,000 2016 seed) to expand direct-to-consumer and physician-distributed sales.
Arzeda raises $3.2M follow-on, bringing total funding to $15.2M to scale computational protein design and fermentation-based materials
Arzeda, which designs custom proteins and materials via fermentation and computational protein design, raised an additional $3.2 million as a follow-on to its $12 million Series A, bringing total funding to $15.2 million to expand its platform and product pipeline across markets like agriculture, advanced materials and specialty chemicals.
RightSciences raises $500,000 to advance cannabis- and hemp-based transdermal pain-relief patches
Seattle startup RightSciences raised $500,000 to develop plant-based transdermal pain-relief patches made from cannabis and hemp, offering non-psychoactive, eight-hour relief as an alternative to OTC painkillers.
Klatu Networks raises $1 million from Seattle angels to scale Traxx predictive IoT for ultra-cold medical freezers
Klatu Networks makes Traxx, an IoT and predictive-analytics system that monitors ultra-low-temperature freezers used to store biologics and warns of impending failures to protect costly vaccines, stem cells and samples. The Seattle/San Diego startup raised $1 million from local angel investors to expand its niche service as biologic therapies—now 60% of the market—drive growing demand.
M3 Biotechnology launches first-in-human trial of NDX-1017 and raises $15.2M to fund Alzheimer’s program
M3 Biotechnology launched a first-in-human clinical trial for its Alzheimer’s candidate NDX-1017, which the company says could slow, halt, or potentially restore neuron damage, and raised $15.2 million to support the effort, bringing total funding above $26 million.
EchoNous raises $35M from KKR, boosting total KKR funding to $70M to scale Signostics’ Uscan and launch AI-driven ultrasound
EchoNous, via its subsidiary Signostics, secured a $35 million investment from KKR — doubling KKR’s total backing to $70 million — to expand adoption of its Uscan intelligent ultrasound and bring a new AI-driven ultrasound project to market.
Petriage raises $400,000 and seeks angel funding to build a pet telehealth app that analyzes symptoms and engages family vets
Seattle startup Petriage is building a telehealth app that analyzes pet symptoms to guide owners during medical emergencies and connects them with their regular vets; the company has raised $400,000 and is now seeking angel funding to expand and hire.
Rodeo Therapeutics raises $5.9M to develop small-molecule 15-PGDH inhibitors for tissue regeneration
Rodeo Therapeutics, a Seattle biotech founded by Case Western and UT researchers, raised $5.9 million to develop small-molecule drugs that stimulate the body’s natural tissue-regeneration processes. Its initial programs target inflammatory bowel disease and hematopoietic recovery after bone marrow transplants by inhibiting the enzyme 15-PGDH.
Arzeda raises $12M Series A to commercialize cloud platform that designs custom proteins for manufacturing and agriculture
Seattle synthetic-biology startup Arzeda raised $12 million in a Series A led by the OS Fund to commercialize a cloud-based platform that designs custom proteins and metabolic pathways for manufacturing, agriculture and other industries.
BloomAPI raises $2.4M to digitize medical records and replace fax/mail workflows
BloomAPI, a Seattle health-tech startup and Y Combinator alum, raised $2.4 million to build software that digitizes and shares medical records, replacing fax- and mail-based workflows that cost the industry an estimated $2.5 billion annually.
Aortica raises $4M round (>$1M closed) to develop AortaFit planning software and BoulEVARd personalized stent for complex abdominal aortic aneurysms
Seattle-area startup Aortica is raising a $4M insider funding round (just over $1M closed so far) to advance its personalized AortaFit planning software and BoulEVARd stent for treating complex abdominal aortic aneurysms, bringing total funding to $11M.
Arivale raises $13.6M toward $30M round, bringing total funding past $50M to scale personalized scientific-wellness platform
Arivale, founded by genomics pioneer Leroy Hood and Clayton Lewis, raised $13.6 million as part of a planned $30 million round to scale its personalized scientific wellness platform; total funding now exceeds $50 million. The company has grown from 19 to 170 employees and uses genetics, blood, gut data and health history to deliver personalized health management.
Carena raises $6M to expand Virtual Clinics platform, total funding tops $30M
Carena, a Seattle-based telemedicine startup, raised $6 million in a funding round—bringing total financing to over $30 million—to expand its Virtual Clinics platform that connects patients with doctors via video for diagnoses of minor illnesses and triage.
Concure Oncology raises $5M from insiders to bring Canadian Breast Microseed therapy to U.S.; available at Swedish Cancer Institute
Concure Oncology raised $5 million from insiders to introduce its Canadian-developed Breast Microseed treatment to the U.S., using implanted radioactive palladium-titanium seeds to deliver targeted post-surgery radiation and reduce breast cancer relapse.
Qliance, once backed by Jeff Bezos and other investors, will close clinics June 1 and shut down June 15 after failing to secure funding
Qliance, a Seattle primary-care startup once backed by Jeff Bezos and other high-profile investors, is shutting its clinics June 1 and will close officially June 15 after failing to secure new funding; a small team will transition patients and cover urgent care and prescriptions.
Heather Redman, Geoff Harris and Frank Chang launch Flying Fish Partners to provide early-stage capital for Seattle startups
Heather Redman and co-founders Geoff Harris and Frank Chang launched Flying Fish Partners, a new Seattle venture fund aiming to solve the city’s lack of organized, aggressive local capital by funding startups early and keeping talent and investment in the region. They emerged from stealth to outline their plan and frustrations with startups leaving for Silicon Valley.
Ventec Life Systems raises $7M (total $28M) to commercialize FDA-cleared VOCSN integrated portable ventilator
Ventec Life Systems, founded by Doug DeVries after his father’s ALS diagnosis, raised $7 million (bringing total funding to $28 million) to commercialize VOCSN, an FDA-cleared portable device that integrates ventilation, oxygen, cough, suction and nebulization to simplify home respiratory care.
Cardiac Insight raises $4.5M and wins FDA approval to launch $20 Cardea Solo seven-day disposable ECG patch
Cardiac Insight raised $4.5 million to commercialize Cardea Solo, a lightweight disposable ECG patch that adheres to the skin for up to seven days and is now FDA-approved and available to healthcare providers; the device can cost as little as $20 and helps detect intermittent cardiac irregularities like atrial fibrillation and tachycardia.